首页 | 本学科首页   官方微博 | 高级检索  
检索        


Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)
Authors:Dena M Carbonari  M Elle Saine  Craig W Newcomb  Betina Blak  Jason A Roy  Kevin Haynes  Jennifer Wood  Arlene M Gallagher  Harshvinder Bhullar  Serena Cardillo  Sean Hennessy  Brian L Strom  Vincent Lo Re III
Institution:1. Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;2. Center for Pharmacoepidemiology Research and Training, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;3. AstraZeneca UK Limited, London, UK;4. HealthCore, Inc., Wilmington, DE, USA;5. Department of Global Pharmacovigilance and Epidemiology, Bristol‐Myers Squibb, Hopewell, NJ, USA;6. Clinical Practice Research Datalink, London, UK;7. IMS Health, London, UK;8. Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;9. Rutgers Biomedical and Health Sciences, Rutgers, the State University of New Jersey, Newark, NJ, USA
Abstract:
Keywords:Clinical Practice Research Datalink (CPRD)  The Health Improvement Network (THIN)  overlap  pharmacoepidemiology
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号